Estradot 37.5 micrograms/24 hours, transdermal patches
Last Updated on eMC 01-Jun-2016 View document | Novartis Pharmaceuticals UK Ltd Contact details
Versions
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 01-Jun-2016 and displayed until Current
Reasons for adding or updating:
- New individual SPC (was previously included in joint SPC)
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Sections 4.4 and 4.8 have also been updated to include further information on ovarian cancer along with making this an individual SmPC.Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
+44 (0)1276 692 255
+44 (0)1276 698 370
+44 (0)845 741 9442
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue